MyAverix Finance
SHE · Healthcare
Medprin Regenerative Medical Technologies Co. Ltd. (301033)
Medical Devices
Medprin Regenerative Medical Technologies Co. Ltd. (301033) is listed on SHE in the Healthcare sector. Industry: Medical Devices. As of 2026-03-28, reported market cap is $4.28B, P/E ratio is 41.43, net margin is 30.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301033
Medprin Regenerative Medical Technologies Co. Ltd. (301033) — FAQ
What is Medprin Regenerative Medical Technologies Co. Ltd.'s market cap?
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a reported market cap of $4.28B (data as of 2026-03-28).
What is 301033's P/E ratio?
The price-to-earnings (P/E) ratio for Medprin Regenerative Medical Technologies Co. Ltd. (301033) is 41.43 (data as of 2026-03-28).
Does Medprin Regenerative Medical Technologies Co. Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Medprin Regenerative Medical Technologies Co. Ltd. (301033). Check the MyAverix Finance app for the latest dividend data.
What sector is Medprin Regenerative Medical Technologies Co. Ltd. in?
Medprin Regenerative Medical Technologies Co. Ltd. (301033) is classified in the Healthcare sector (Medical Devices industry).
What exchange is 301033 listed on?
301033 is listed on SHE.
What is Medprin Regenerative Medical Technologies Co. Ltd.'s net margin?
Medprin Regenerative Medical Technologies Co. Ltd. (301033) reports a net margin of 30.3% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.